OrgUnit's Researchers
(Persons)

Results 1-5 of 27 (Search time: 0.0 seconds).

FullnameTranslated NameEmail
Angus, Daviddavid.angus@austin.org.au
Bolton, Damien MDamien.BOLTON@austin.org.au
Chan, Garsongarson.chan@austin.org.au
Chan, Yeeyee.chan@austin.org.au
Chee, Justinjustin.chee@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 1-20 of 472 (Search time: 0.002 seconds).

Publication YearTitleAuthor(s)
11-Feb-201418F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.Mertens, Laura S; Mir, M Carmen; Scott, Andrew M ; Lee, Sze Ting ; Fioole-Bruining, Annemarie; Vegt, Erik; Vogel, Wouter V; Manecksha, Rustom; Bolton, Damien M ; Davis, Ian D; Horenblas, Simon; van Rhijn, Bas W G; Lawrentschuk, Nathan
2Oct-201624-month durability after crossover to the prostatic urethral lift from randomised, blinded shamRukstalis, Daniel; Rashid, Prem; Bogache, William; Tutrone, Ronald; Barkin, Jack; Chin, Peter; Woo, Henry; Cantwell, Anthony; Cowan, Barrett; Bolton, Damien M 
320233D printed patient-specific prostate cancer models to guide nerve-sparing robot-assisted radical prostatectomy: a systematic review.Coles-Black, Jasamine ; Ong, Sean; Teh, Jiasian ; Kearns, Paul; Ischia, Joseph J ; Bolton, Damien M ; Lawrentschuk, Nathan
431-Mar-20235-alpha reductase inhibitors use in prostatic disease and beyond.Chislett, Bodie ; Chen, David; Perera, Marlon ; Chung, Eric; Bolton, Damien M ; Qu, Liang G 
5Apr-201868Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic reviewCorfield, Julia; Perera, Marlon ; Bolton, Damien M ; Lawrentschuk, Nathan
6Dec-201768Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends.Udovicich, Cristian; Perera, Marlon ; Hofman, Michael S; Siva, Shankar; Del Rio, Andres ; Murphy, Declan G; Lawrentschuk, Nathan
7May-2019A blind spot in urology: Prostate cancer associated retinopathy.Duncan, Catriona; Zamir, Ehud; Teh, Jiasian ; Joon, Daryl Lim; Liodakis, Peter 
8Nov-2019A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer.Roberts, Matthew J; Papa, Nathan; Perera, Marlon ; Scott, Susan; Teloken, Patrick E; Joshi, Andre; Vela, Ian; Pryor, David; Martin, Jarad; Woo, Henry
9Nov-2019A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer.Sathianathen, Niranjan J; Alarid-Escudero, Fernando; Kuntz, Karen M; Lawrentschuk, Nathan; Bolton, Damien M ; Murphy, Declan G; Kim, Simon P; Konety, Badrinath R
10Dec-2022A decade of declining prostatectomy margin positivity within a prostate cancer clinical quality registry.Papa, Nathan; Perera, Marlon ; Bensley, Jonathan G; Evans, Melanie; Millar, Jeremy; Frydenberg, Mark; Murphy, Declan G; Bolton, Damien M 
112019A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).Ahn, Thomas; Roberts, Matthew J; Abduljabar, Aous; Joshi, Andre; Perera, Marlon ; Rhee, Handoo; Wood, Simon; Vela, Ian
12May-2020A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation.Ellis, Robert J; Del Vecchio, Sharon J; Gallagher, Kevin M J; Aliano, Danielle N; Barber, Neil; Bolton, Damien M ; Chew, Etienne T S; Coombes, Jeff S; Coory, Michael D; Davis, Ian D; Donaldson, James F; Francis, Ross S; Giles, Graham G; Gobe, Glenda C; Hawley, Carmel M; Johnson, David W; Laird, Alexander; Leung, Steve; Malki, Manar; Marco, David J T; McNeill, Alan S; Neale, Rachel E; Ng, Keng L; Phipps, Simon; Stewart, Grant D; White, Victoria M; Wood, Simon T; Jordan, Susan J
13Jul-2019A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy.Sathianathen, Niranjan J; Jarosek, Stephanie; Lawrentschuk, Nathan; Bolton, Damien M ; Konety, Badrinath R
14Apr-2018A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.Chao, Michael ; Spencer, Sandra; Guerrieri, Mario; Ding, Wei; Goharian, Mehran; Ho, Huong; Ng, Michael; Healey, Danielle; Tan, Alwin; Cham, Chee; Joon, Daryl Lim; Lawrentschuk, Nathan; Travis, Douglas; Sengupta, Shomik ; Chan, Yee ; Troy, Andrew; Pham, Trung; Clarke, David; Liodakis, Peter ; Bolton, Damien M 
154-Jun-2020A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer.Holmes, A; Kelly, Brian D ; Perera, Marlon ; Eapen, Renu S ; Bolton, Damien M ; Lawrentschuk, Nathan
1627-Jan-2021Accessing 3D Printed Vascular Phantoms for Procedural Simulation.Coles-Black, Jasamine ; Bolton, Damien M ; Chuen, Jason 
1714-Aug-2018Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis.Sathianathen, Niranjan J; Butaney, Mohit; Bongiorno, Connie; Konety, Badrinath R; Bolton, Damien M ; Lawrentschuk, Nathan
181-Sep-2014Active surveillance in patients with a PSA >10 ng/mL.Toren, Paul; Wong, Lih-Ming ; Timilshina, Narhari; Alibhai, Shabbir; Trachtenberg, John; Fleshner, Neil; Finelli, Antonio
1925-Jul-2022Active surveillance versus enzalutamide for low-risk prostate cancer- was it really a trial we needed?Williams, Isabella Sc; Perera, Sachin; Murphy, Declan G; Corcoran, Niall M; Bolton, Damien M ; Lawrentschuk, Nathan
20May-2022Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage.Balasubramanian, Adithya ; Gunjur, Ashray ; Weickhardt, Andrew J ; Papa, Nathan; Bolton, Damien M ; Lawrentschuk, Nathan; Perera, Marlon